Literature DB >> 33310881

RIPK1 Distinctly Regulates Yersinia-Induced Inflammatory Cell Death, PANoptosis.

R K Subbarao Malireddi1, Sannula Kesavardhana1, Rajendra Karki1, Balabhaskararao Kancharana1, Amanda R Burton1, Thirumala-Devi Kanneganti2.   

Abstract

Bacterial pathogens from the genus Yersinia cause fatal sepsis and gastritis in humans. Innate immune signaling and inflammatory cell death (pyroptosis, apoptosis, and necroptosis [PANoptosis]) serve as a first line of antimicrobial host defense. The receptor-interacting protein kinase 1 (RIPK1) is essential for Yersinia-induced pyroptosis and apoptosis and an effective host response. However, it is not clear whether RIPK1 assembles a multifaceted cell death complex capable of regulating caspase-dependent pyroptosis and apoptosis or whether there is cross-talk with necroptosis under these conditions. In this study, we report that Yersinia activates PANoptosis, as evidenced by the concerted activation of proteins involved in PANoptosis. Genetic deletion of RIPK1 abrogated the Yersinia-induced activation of the inflammasome/pyroptosis and apoptosis but enhanced necroptosis. We also found that Yersinia induced assembly of a RIPK1 PANoptosome complex capable of regulating all three branches of PANoptosis. Overall, our results demonstrate a role for the RIPK1 PANoptosome in Yersinia-induced inflammatory cell death and host defense.
Copyright © 2020 The Authors.

Entities:  

Year:  2020        PMID: 33310881      PMCID: PMC7906112          DOI: 10.4049/immunohorizons.2000097

Source DB:  PubMed          Journal:  Immunohorizons        ISSN: 2573-7732


  52 in total

1.  Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes.

Authors:  Mohamed Lamkanfi; Thirumala-Devi Kanneganti; Petra Van Damme; Tom Vanden Berghe; Isabel Vanoverberghe; Joël Vandekerckhove; Peter Vandenabeele; Kris Gevaert; Gabriel Núñez
Journal:  Mol Cell Proteomics       Date:  2008-07-30       Impact factor: 5.911

2.  YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells.

Authors:  L E Palmer; A R Pancetti; S Greenberg; J B Bliska
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

3.  Serine/threonine acetylation of TGFβ-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling.

Authors:  Nicholas Paquette; Joseph Conlon; Charles Sweet; Florentina Rus; Lindsay Wilson; Andrea Pereira; Charles V Rosadini; Nadege Goutagny; Alexander N R Weber; William S Lane; Scott A Shaffer; Stephanie Maniatis; Katherine A Fitzgerald; Lynda Stuart; Neal Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

4.  IRF8 Regulates Transcription of Naips for NLRC4 Inflammasome Activation.

Authors:  Rajendra Karki; Ein Lee; David Place; Parimal Samir; Jayadev Mavuluri; Bhesh Raj Sharma; Arjun Balakrishnan; R K Subbarao Malireddi; Rechel Geiger; Qifan Zhu; Geoffrey Neale; Thirumala-Devi Kanneganti
Journal:  Cell       Date:  2018-03-22       Impact factor: 41.582

5.  Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-κB and MAPK signaling.

Authors:  Naomi H Philip; Christopher P Dillon; Annelise G Snyder; Patrick Fitzgerald; Meghan A Wynosky-Dolfi; Erin E Zwack; Baofeng Hu; Louise Fitzgerald; Elizabeth A Mauldin; Alan M Copenhaver; Sunny Shin; Lei Wei; Matthew Parker; Jinghui Zhang; Andrew Oberst; Douglas R Green; Igor E Brodsky
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

6.  RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.

Authors:  Marius Dannappel; Katerina Vlantis; Snehlata Kumari; Apostolos Polykratis; Chun Kim; Laurens Wachsmuth; Christina Eftychi; Juan Lin; Teresa Corona; Nicole Hermance; Matija Zelic; Petra Kirsch; Marijana Basic; Andre Bleich; Michelle Kelliher; Manolis Pasparakis
Journal:  Nature       Date:  2014-08-17       Impact factor: 49.962

7.  Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense.

Authors:  Min Zheng; Rajendra Karki; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  Cell       Date:  2020-04-15       Impact factor: 41.582

8.  RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition.

Authors:  William J Kaiser; Lisa P Daley-Bauer; Roshan J Thapa; Pratyusha Mandal; Scott B Berger; Chunzi Huang; Aarthi Sundararajan; Hongyan Guo; Linda Roback; Samuel H Speck; John Bertin; Peter J Gough; Siddharth Balachandran; Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

9.  ZBP1/DAI ubiquitination and sensing of influenza vRNPs activate programmed cell death.

Authors:  Sannula Kesavardhana; Teneema Kuriakose; Clifford S Guy; Parimal Samir; R K Subbarao Malireddi; Ashutosh Mishra; Thirumala-Devi Kanneganti
Journal:  J Exp Med       Date:  2017-06-20       Impact factor: 14.307

10.  ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis).

Authors:  Balaji Banoth; Shraddha Tuladhar; Rajendra Karki; Bhesh Raj Sharma; Benoit Briard; Sannula Kesavardhana; Amanda Burton; Thirumala-Devi Kanneganti
Journal:  J Biol Chem       Date:  2020-10-27       Impact factor: 5.157

View more
  19 in total

Review 1.  Programming inflammatory cell death for therapy.

Authors:  Shelbi Christgen; Rebecca E Tweedell; Thirumala-Devi Kanneganti
Journal:  Pharmacol Ther       Date:  2021-10-04       Impact factor: 12.310

2.  Gout-associated monosodium urate crystal-induced necrosis is independent of NLRP3 activity but can be suppressed by combined inhibitors for multiple signaling pathways.

Authors:  Chun-Su Zhong; Bo Zeng; Jia-Hao Qiu; Li-Hui Xu; Mei-Yan Zhong; Yuan-Ting Huang; Rong Xu; Si-Ying Liu; Qing-Bing Zha; Bo Hu; Dong-Yun Ou-Yang; Xian-Hui He
Journal:  Acta Pharmacol Sin       Date:  2021-08-10       Impact factor: 7.169

3.  Single cell analysis of PANoptosome cell death complexes through an expansion microscopy method.

Authors:  Yaqiu Wang; Nagakannan Pandian; Joo-Hui Han; Balamurugan Sundaram; SangJoon Lee; Rajendra Karki; Clifford S Guy; Thirumala-Devi Kanneganti
Journal:  Cell Mol Life Sci       Date:  2022-09-28       Impact factor: 9.207

4.  NLRC4 Deficiency Leads to Enhanced Phosphorylation of MLKL and Necroptosis.

Authors:  Balamurugan Sundaram; Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Immunohorizons       Date:  2022-03-17

Review 5.  PANoptosis: A Unique Innate Immune Inflammatory Cell Death Modality.

Authors:  Nagakannan Pandian; Thirumala-Devi Kanneganti
Journal:  J Immunol       Date:  2022-11-01       Impact factor: 5.426

6.  The IFN-inducible GTPase IRGB10 regulates viral replication and inflammasome activation during influenza A virus infection in mice.

Authors:  Shelbi Christgen; David E Place; Min Zheng; Benoit Briard; Masahiro Yamamoto; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2021-11-09       Impact factor: 5.532

Review 7.  The 'cytokine storm': molecular mechanisms and therapeutic prospects.

Authors:  Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Trends Immunol       Date:  2021-07-01       Impact factor: 19.709

Review 8.  Innate immunity: the first line of defense against SARS-CoV-2.

Authors:  Michael S Diamond; Thirumala-Devi Kanneganti
Journal:  Nat Immunol       Date:  2022-02-01       Impact factor: 31.250

9.  Inflammatory Cell Death, PANoptosis, Mediated by Cytokines in Diverse Cancer Lineages Inhibits Tumor Growth.

Authors:  R K Subbarao Malireddi; Rajendra Karki; Balamurugan Sundaram; Balabhaskararao Kancharana; SangJoon Lee; Parimal Samir; Thirumala-Devi Kanneganti
Journal:  Immunohorizons       Date:  2021-07-21

10.  Hierarchical Cell Death Program Disrupts the Intracellular Niche Required for Burkholderia thailandensis Pathogenesis.

Authors:  David E Place; Shelbi Christgen; Shraddha Tuladhar; Peter Vogel; R K Subbarao Malireddi; Thirumala-Devi Kanneganti
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.